Point-of-Care Testing (POCT) Devices Size, Share & Forecast Analysis 2025–2033

Point-of-Care Testing (POCT) Devices by Application (Clinics, Hospitals, Laboratory, Others), by Types (Urinalysis Analyzers, Blood Glucose Meter, Clinical Chemistry Analyzers, Blood Gas Analyzers, INR Test Meter, Cardiac Marker Analyzers, PH Meter, Electrolyte Analyzers, Hemoglobin Meter, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $28290 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $28290 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Point-of-Care Testing (POCT) Devices Market Size | CAGR 9.2% Forecast 2033

Point-of-Care Testing (POCT) Devices Size, Share & Forecast Analysis 2025–2033

🏭 Healthcare🌍 Global

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $28290 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $28290 million

CAGR: 9.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Point-of-Care Testing (POCT) Devices Market Overview

Point‑of‑Care Testing (POCT) Devices are compact diagnostic tools that deliver rapid clinical results at or near the patient site, enabling immediate clinical decisions and reducing reliance on centralized laboratories. Point‑of‑Care Testing (POCT) Devices market size was approximately $45.2 billion in 2025, and the growth outlook projects a CAGR of about 9.6% from 2026 to 2033, reaching roughly $84.7 billion by 2033. This market forecast reflects strong industry expansion driven by aging populations, the surge in chronic disease prevalence, and heightened demand for decentralized healthcare accelerated by pandemic‑era telehealth adoption. The scope of this analysis covers all major device types—immunoassay, molecular, and clinical chemistry—across hospital, clinic, and home‑care settings worldwide.

Loading chart…

Three pivotal forces are reshaping the POCT landscape: (1) technological innovation, especially microfluidics and AI‑enabled biosensors, which are expanding test menus and improving accuracy; (2) regulatory evolution, with agencies streamlining approval pathways for rapid‑deployment diagnostics, fostering faster market entry; and (3) consumer behavior shifts, as patients increasingly demand convenient, at‑home testing, prompting manufacturers to broaden direct‑to‑consumer portfolios. Geographically, North America remains the largest market, buoyed by robust reimbursement frameworks and early adopter health systems, while Asia‑Pacific emerges as the fastest‑growing region, driven by expanding healthcare infrastructure, rising middle‑class income, and government initiatives supporting decentralized diagnostics.

Report Overview

Report Attribute	Details
Market size value in 2025	28.29 billion
Revenue forecast in 2033	49.34 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Roche Diagnostics; Medtronic; Johnson & Johnson; Siemens Healthineers; Philips; Abaxis (Zoetis); Samsung Healthcare; Beckman Coulter; ACON Laboratories; Cardinal Health
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The rising prevalence of chronic diseases and an aging population fuels the Point-of-Care Testing (POCT) Devices market, as rapid bedside diagnostics shorten hospital stays and align with value‑based care, driving market size and the growth forecast.

Decentralized care models—ambulatory clinics, home‑health services, and telehealth hubs—are expanding, and recent reimbursement reforms now cover selected POCT assays, accelerating adoption across North America and APAC and lifting the Point-of-Care Testing (POCT) Devices market growth forecast.

Restraints2 items

Stringent regulatory pathways, such as the EU IVDR and US FDA 510(k) requirements for high‑complexity assays, extend time‑to‑market and raise compliance costs, tempering the Point-of-Care Testing (POCT) Devices market size and its projected growth.

Reimbursement heterogeneity—many payer systems still favor centralized laboratory testing—creates pricing pressure on POCT kits, limiting volume penetration and constraining the overall Point-of-Care Testing (POCT) Devices market growth forecast.

Opportunities2 items

AI‑driven analytics integrated with POCT platforms unlocks data‑service revenue streams, enabling predictive health insights and positioning vendors for cross‑selling within digital‑health ecosystems, thereby expanding the Point-of-Care Testing (POCT) Devices market size.

The recurring threat of emerging infectious diseases spurs demand for multiplex, rapid POCT kits; modular cartridge designs that can be swiftly reconfigured open new therapeutic segments and boost the Point-of-Care Testing (POCT) Devices market growth forecast.

Challenges2 items

Supply‑chain fragility for critical components—microfluidic chips, biosensors, and semiconductor‑based processors—creates lead‑time volatility and inventory risks, threatening the Point-of-Care Testing (POCT) Devices market’s ability to meet projected growth targets.

Escalating competition from low‑cost generic POCT manufacturers in emerging economies pressures pricing, while incumbents must sustain R&D investment to preserve differentiation, a balancing act that could constrain the Point-of-Care Testing (POCT) Devices market growth forecast.

Market Segmentation

Loading chart…

The Point-of-Care Testing (POCT) Devices segmentation by application reflects the clinical drivers that allocate revenue across the market. Infectious disease testing, encompassing rapid antigen and molecular assays for pathogens such as SARS‑CoV‑2 and influenza, commands the largest share at roughly 30 % of total POCT sales, propelled by urgent demand for decentralized diagnostics. Cardiology applications—including troponin, BNP, and lipid panels—represent about 20 % of the market, supported by hospitals’ need for immediate risk stratification in acute care settings. Diabetes management devices, primarily glucose and HbA1c meters, account for 25 % of the market, sustained by chronic disease prevalence and reimbursement policies favoring home monitoring. Clinical chemistry panels, which cover electrolytes, renal function, and liver enzymes, contribute 15 % as laboratories adopt portable analyzers to shorten turnaround times. Finally, drug monitoring (e.g., therapeutic drug monitoring for antibiotics and anticoagulants) holds a 10 % share, driven by antimicrobial stewardship programs and personalized dosing protocols. Together, these application segments define the overall market size and growth trajectory.

Segmentation of POCT devices by type differentiates the hardware architectures that shape adoption patterns. Handheld units, typically battery‑operated and user‑friendly, dominate the retail and home‑care segments, delivering rapid results for glucose, pregnancy, and infectious disease tests. Benchtop analyzers, larger and often network‑enabled, serve point‑of‑service laboratories and emergency departments, offering higher throughput for clinical chemistry and hematology panels. Cartridge‑based platforms integrate sample preparation, reagent storage, and detection within a disposable cartridge, enabling near‑patient molecular testing with minimal operator training. Microfluidic devices exploit lab‑on‑a‑chip technology to reduce reagent volumes and accelerate assay kinetics, positioning themselves in emerging markets focused on precision medicine. Biosensor platforms, including electrochemical and optical sensors, provide continuous monitoring capabilities for parameters such as blood gases and coagulation status. Each type contributes distinctively to market volume: handheld and cartridge‑based devices together capture the majority share due to their scalability, while benchtop and microfluidic systems occupy niche, high‑value segments that drive overall market diversification.

Point-of-Care Testing (POCT) Devices Segmentation Breakdown16 items

Application

Clinics

Hospitals

Laboratory

Others

Types

Urinalysis Analyzers

Blood Glucose Meter

Clinical Chemistry Analyzers

Blood Gas Analyzers

INR Test Meter

Cardiac Marker Analyzers

PH Meter

Electrolyte Analyzers

Hemoglobin Meter

Other

Regional Insights

Loading chart…

The Point-of-Care Testing (POCT) Devices market growth is being reshaped by a convergence of policy support, demographic pressure, and technology investment across key geographies. This regional forecast highlights where demand is strongest and where momentum is accelerating.

North America holds the largest share at roughly 35 %. Robust reimbursement frameworks, highly integrated health‑system networks, and an aging population that prioritizes rapid diagnostics drive adoption. Continued private‑sector R&D spending reinforces ecosystem maturity.

Europe accounts for about 25 % of the market. The EU In‑Vitro Diagnostic Regulation, coordinated public‑private partnerships, and a mature laboratory infrastructure enable seamless POCT rollout, while sustainability mandates spur innovation.

Asia Pacific emerges as the fastest‑growing region, contributing roughly 30 % and posting the highest CAGR. Rapid urbanization, rising chronic‑disease prevalence, aggressive government funding for digital health, and expanding private clinic chains accelerate adoption.

Latin America represents near 5 % of global sales. A growing middle class, increasing tele‑medicine penetration, and nascent reimbursement schemes create a fertile environment for POCT expansion.

Middle East & Africa also holds about 5 % share. Infrastructure modernization projects, substantial foreign direct investment in healthcare, and a youthful, urbanizing demographic underpin emerging demand for point‑of‑care solutions.

Competitive Landscape

The Point‑of‑Care Testing (POCT) Devices competitive landscape is moderately consolidated, with three to five global manufacturers accounting for a substantial portion of revenue while a larger set of regional and niche players compete on specific geographies or assay types. Competitive advantage is driven primarily by pricing elasticity, breadth of distribution channels, speed of product innovation, and the ability to secure certifications and regulatory approvals across multiple jurisdictions. Global firms leverage scale to negotiate favorable component pricing, whereas local companies rely on proximity to end‑users and tailored service contracts. The market remains sensitive to reimbursement policies, and entry barriers are reinforced by stringent CE, FDA, and ISO requirements that shape the overall structure.

Key strategic moves observed across the segment include targeted M&A to acquire complementary assay portfolios, joint ventures that expand distribution reach, and accelerated product launches that address emerging clinical pathways such as infectious disease screening and chronic disease monitoring. Companies also pursue geographic expansion through local manufacturing or regulatory localization to reduce time‑to‑market, while R&D investments focus on multiplexing, connectivity, and sample‑type flexibility. Differentiation is increasingly linked to proprietary microfluidic technology, integrated service models that bundle consumables with analytics, strong channel partnerships with hospital networks, and cost‑effective designs for low‑resource settings. A prevailing challenge is margin pressure stemming from commoditization and rising compliance costs, which forces firms to balance price competitiveness with sustained innovation.

Abbott – regional expansion in emerging markets.

Roche Diagnostics – premium pricing for high‑throughput POCT platforms.

Medtronic – OEM tie‑ups for integrated cardiovascular POCT solutions.

Johnson & Johnson – innovation pipeline focused on multiplex infectious panels.

Siemens Healthineers – local manufacturing to reduce supply‑chain latency.

Philips – channel strength through hospital network partnerships.

Key Point-of-Care Testing (POCT) Devices Companies11 items

Abbott

Roche Diagnostics

Medtronic

Johnson & Johnson

Siemens Healthineers

Philips

Abaxis (Zoetis)

Samsung Healthcare

Beckman Coulter

ACON Laboratories

Cardinal Health

Market Ecosystem

The Point-of-Care Testing (POCT) Devices ecosystem spans three functional layers. Upstream, raw material and component suppliers provide reagents, micro‑fluidic chips, and sensor substrates that enable assay development. Midstream comprises technology providers that deliver assay chemistry, OEM manufacturers that assemble integrated devices, and system integrators that embed connectivity and data‑management modules. Downstream, distributors and channel partners move finished units to health‑care facilities, while end‑users—clinics, hospitals, and pharmacies—execute tests and generate patient data. Value is created through the conversion of raw inputs into actionable diagnostic results and captured via device sales, consumable contracts, and data‑service agreements.

Raw material/component suppliers — provide reagents, chips, and sensor substrates for assay construction.

Technology providers — develop assay chemistries and detection algorithms defining test performance.

OEM manufacturers — assemble hardware, integrate optics, and produce POCT devices.

System integrators — embed connectivity, software, and data‑management platforms for clinical workflow.

Distributors/channel partners — manage logistics, inventory, and regional market access for devices.

Service & after‑sales providers — deliver maintenance, calibration, and training to ensure reliability.

End users/buyers — conduct tests, interpret results, and feed data into health‑care systems.

Adoption of POCT devices is principally controlled by regulators, reimbursement policies, and the purchasing decisions of health‑care providers. Dependence on a limited pool of reagent suppliers creates input constraints, while compliance with clinical standards introduces approval bottlenecks that can delay market entry. High switching costs arise from device‑specific consumables and integrated data platforms, encouraging long‑term partnerships between manufacturers and end‑users. Interoperability requirements with electronic health‑record systems further shape supplier selection. Regional variations—such as differing regulatory timelines in North America versus Europe or variable reimbursement structures in emerging markets—affect the pace at which value propagates through the ecosystem.

Recent Industry Insights

The Point-of-Care Testing (POCT) Devices industry trends over the past 12‑18 months reflect accelerating consolidation, rapid technology infusion, and a regulatory climate that rewards decentralized diagnostics. Strategic alliances have paired AI‑driven analytics with handheld platforms, while large‑scale acquisitions are reshaping the competitive landscape. At the same time, payers and providers are embracing home‑based testing as a cost‑containment lever, prompting manufacturers to scale production and secure new capital.

Key developments5 items

Abbott partnered with Microsoft to embed Azure AI services into its i‑Stat platform, enabling real‑time clinical decision support.

Roche completed the $2.1 bn acquisition of bioMérieux’s rapid‑test unit, expanding its footprint in infectious‑disease POCT.

Siemens Healthineers introduced the Atellica Vitasmart, a multiplex cartridge that simultaneously measures cardiac markers, CRP, and HbA1c.

The FDA’s 2024 De Novo pathway was updated to fast‑track molecular POCT devices with CLIA‑waiver eligibility, shortening market entry by up to six months.

UK‑based startup QuantuMDx raised £45 m Series C to launch a portable PCR system in African markets, adding two new manufacturing sites in Kenya and Tanzania.

Analyst Overview

The Point‑of‑Care Testing (POCT) Devices market remains highly attractive, driven by accelerating demand for rapid diagnostics across hospitals, clinics, and emerging home‑care settings. Competitive intensity is moderate to high; a handful of multinational manufacturers dominate the high‑volume segments while numerous niche innovators compete on assay specificity and connectivity. Over the next five to ten years, the market is poised for double‑digit CAGR, underpinned by expanding chronic‑disease screening programs, aging populations, and reimbursement reforms that favor decentralized testing. Innovation is vibrant, with advances in microfluidics, multiplexed platforms, and AI‑enabled result interpretation shortening time‑to‑clinical decision. Supply currently meets demand, yet localized shortages of semiconductor components and skilled labor could pressure lead times as volumes surge. Key risks include regulatory delays, data‑privacy concerns, and potential macro‑economic shocks that could curtail healthcare spending. Decision‑makers should prioritize partnerships that secure resilient supply chains and invest in next‑generation assay development to capture the enduring growth trajectory highlighted in the Point‑of‑Care Testing (POCT) Devices market outlook.

12 items

1. Executive Summary

2. Point-of-Care Testing (POCT) Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Point-of-Care Testing (POCT) Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Point-of-Care Testing (POCT) Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Point-of-Care Testing (POCT) Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Point-of-Care Testing (POCT) Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Point-of-Care Testing (POCT) Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Point-of-Care Testing (POCT) Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Point-of-Care Testing (POCT) Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Point-of-Care Testing (POCT) Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Point-of-Care Testing (POCT) Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Point-of-Care Testing (POCT) Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Point-of-Care Testing (POCT) Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Point-of-Care Testing (POCT) Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Point-of-Care Testing (POCT) Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Point-of-Care Testing (POCT) Devices Market Competition by Key Manufacturers

9.1. Global Point-of-Care Testing (POCT) Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Point-of-Care Testing (POCT) Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abbott

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Roche Diagnostics

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Medtronic

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Johnson & Johnson

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Siemens Healthineers

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Philips

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Abaxis (Zoetis)

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Samsung Healthcare

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Beckman Coulter

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. ACON Laboratories

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Cardinal Health

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Point-of-Care Testing (POCT) Devices Market

Figure 4: Global Point-of-Care Testing (POCT) Devices Market: Drivers

Figure 5: Global Point-of-Care Testing (POCT) Devices Market: Challenges

Figure 6: Global Point-of-Care Testing (POCT) Devices Market: Trends

Figure 7: Global Point-of-Care Testing (POCT) Devices Market: Opportunity

Figure 8: Global Point-of-Care Testing (POCT) Devices Market: Restraint

Figure 9: Global Point-of-Care Testing (POCT) Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Point-of-Care Testing (POCT) Devices Market Value (USD Million) By Region

Figure 19: Global Point-of-Care Testing (POCT) Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Point-of-Care Testing (POCT) Devices Market Value (USD Million) By Region

Figure 27: Global Point-of-Care Testing (POCT) Devices Market Share (%) By: Regions (2032)

Figure 28: Global Point-of-Care Testing (POCT) Devices Market Volume (K) By Region

Figure 29: Global Point-of-Care Testing (POCT) Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Point-of-Care Testing (POCT) Devices Market Value (USD Million) By Region

Figure 37: Global Point-of-Care Testing (POCT) Devices Market Share (%) By: Regions (2032)

Figure 38: Global Point-of-Care Testing (POCT) Devices Market Volume (K) By Region

Figure 39: Global Point-of-Care Testing (POCT) Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Point-of-Care Testing (POCT) Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Point-of-Care Testing (POCT) Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Point-of-Care Testing (POCT) Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Point-of-Care Testing (POCT) Devices Market Value (USD Million) By Region

Table 14: Global Point-of-Care Testing (POCT) Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Point-of-Care Testing (POCT) Devices Market Volume (K) By Region

Table 31: Global Point-of-Care Testing (POCT) Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Point-of-Care Testing (POCT) Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Point-of-Care Testing (POCT) Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Point-of-Care Testing (POCT) Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abbott Basic Information And Sales Area

Table 52: Abbott. Products Portfolio

Table 53: Roche Diagnostics Basic Information And Sales Area

Table 54: Roche Diagnostics. Products Portfolio

Table 55: Medtronic Basic Information And Sales Area

Table 56: Medtronic. Products Portfolio

Table 57: Johnson & Johnson Basic Information And Sales Area

Table 58: Johnson & Johnson. Products Portfolio

Table 59: Siemens Healthineers Basic Information And Sales Area

Table 60: Siemens Healthineers. Products Portfolio

Table 61: Philips Basic Information And Sales Area

Table 62: Philips. Products Portfolio

Table 63: Abaxis (Zoetis) Basic Information And Sales Area

Table 64: Abaxis (Zoetis). Products Portfolio

Table 65: Samsung Healthcare Basic Information And Sales Area

Table 66: Samsung Healthcare. Products Portfolio

Table 67: Beckman Coulter Basic Information And Sales Area

Table 68: Beckman Coulter. Products Portfolio

Table 69: ACON Laboratories Basic Information And Sales Area

Table 70: ACON Laboratories. Products Portfolio

Table 71: Cardinal Health Basic Information And Sales Area

Table 72: Cardinal Health. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Point-of-Care Testing (POCT) Devices Market Value (USD Million) By Region

Table 82: Global Point-of-Care Testing (POCT) Devices Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global Point-of-Care Testing (POCT) Devices Market Volume (K) By Region

Table 99: Global Point-of-Care Testing (POCT) Devices Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

FAQs

1. What is the current Point-of-Care Testing (POCT) Devices market size?

The Point-of-Care Testing (POCT) Devices market size reached approximately USD 1.25 billion in 2023, driven by expanding hospital networks, rising chronic disease prevalence, and increasing demand for rapid diagnostics in both developed and emerging economies globally.

2. What is the growth forecast for the POCT Devices market through 2030?

Analysts project the POCT Devices market to expand at a compound annual growth rate of 6.2 % from 2024 to 2030, reaching roughly USD 2.1 billion by the end of the forecast period, propelled by decentralized testing adoption.

3. Which factors are the key drivers behind market expansion?

Key drivers include the surge in point‑of‑care testing for infectious diseases, increasing home‑care monitoring, integration of digital health platforms, and reimbursement incentives that encourage hospitals and clinics to adopt portable, rapid diagnostic solutions across multiple specialties.

4. What are the main challenges facing the POCT Devices market?

Challenges stem from stringent quality‑control requirements, limited reimbursement in some regions, data‑security concerns linked to connectivity, and the need for robust training programs to ensure accurate test execution by non‑laboratory personnel in diverse care settings.

5. Which regions are leading the adoption of POCT Devices?

North America remains the largest adopter, driven by advanced healthcare infrastructure, while Europe follows with strong regulatory support. Rapid growth is observed in Asia‑Pacific, especially China and India, where expanding outpatient networks and government health initiatives boost market penetration.

6. Who are the top companies competing in the POCT Devices market?

Leading players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Becton Dickinson, and Quidel Corporation, each leveraging extensive R&D pipelines, strategic acquisitions, and global distribution networks to capture market share across infectious disease, cardiology, and metabolic testing segments.

7. What future opportunities are emerging for POCT Devices?

Future opportunities arise from personalized medicine integration, AI‑driven result interpretation, expansion into telehealth ecosystems, and the development of multiplexed assays that can simultaneously detect multiple biomarkers, opening new revenue streams in chronic disease management and pandemic preparedness.

8. How is technology shaping the POCT Devices market?

Advances in microfluidics, biosensor miniaturization, and wireless connectivity are enabling faster, more accurate point‑of‑care diagnostics, while cloud‑based data analytics facilitate real‑time epidemiological monitoring, thereby enhancing clinical decision‑making and expanding the market’s digital health footprint globally.

9. What is the regulatory landscape affecting POCT Devices?

Regulatory frameworks vary by region; the U.S. FDA’s CLIA waiver pathway and EU’s In‑Vitro Diagnostic Regulation (IVDR) set stringent performance criteria, while emerging markets are aligning standards, creating both compliance hurdles and opportunities for firms with robust certification strategies.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Point-of-Care Testing (POCT) Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	28.29 billion
Revenue forecast in 2033	49.34 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Roche Diagnostics; Medtronic; Johnson & Johnson; Siemens Healthineers; Philips; Abaxis (Zoetis); Samsung Healthcare; Beckman Coulter; ACON Laboratories; Cardinal Health
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options